Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 76 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/14/16
End: 07/01/18
Due: 07/01/19
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 04/30/11
Due: 04/30/12
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 10/15/17
End: 08/25/19
Due: 08/25/20
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 05/31/11
Due: 05/31/12
An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 11/30/18
Due: 11/30/19
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 09/30/13
Due: 09/30/14
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 11/15/21
Due: 11/15/22
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 07/08/12
Due: 07/08/13
Phase: N/A
Priority: Normal
Start: 11/01/12
End: 07/29/19
Due: 07/29/20
Phase: N/A
Priority: Normal
Start: 11/01/12
End: 12/01/14
Due: 12/01/15
Phase: N/A
Priority: Normal
Start: 01/31/18
End: 10/04/19
Due: 10/04/20
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 07/31/06
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 11/30/13
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 05/01/11
End: 07/01/16
Due: 07/01/17
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 11/30/11
Due: 11/30/12
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 06/30/12
Due: 06/30/13